Asaf Poran

机构：BioNTech (United States) · ORCID：0000-0001-9118-1051

发表论文 64 篇 · 总被引 4441 次 · h-index 21

代表论文

• BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans (2021 · Nature · 被引 843)
• A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer (2020 · Cell · 被引 763)
• Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera (2022 · Science · 被引 390)
• Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer (2022 · Cancer Cell · 被引 229)
• BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans (2020 · medRxiv · 被引 171)
• A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease (2024 · Cell · 被引 157)